Amphastar Ebitda from 2010 to 2025

AMPH Stock  USD 24.86  0.54  2.22%   
Amphastar's EBITDA is increasing with slightly volatile movements from year to year. EBITDA is estimated to finish at about 291.2 M this year. For the period between 2010 and 2025, Amphastar, EBITDA quarterly trend regression had median of  30,256,000 and r-value of  0.82. View All Fundamentals
 
EBITDA  
First Reported
2012-12-31
Previous Quarter
65.1 M
Current Value
37.3 M
Quarterly Volatility
24 M
 
Yuan Drop
 
Covid
Check Amphastar financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amphastar's main balance sheet or income statement drivers, such as Depreciation And Amortization of 60.1 M, Interest Expense of 31.9 M or Selling General Administrative of 47.3 M, as well as many indicators such as Price To Sales Ratio of 1.95, Dividend Yield of 0.0 or PTB Ratio of 1.81. Amphastar financial statements analysis is a perfect complement when working with Amphastar Valuation or Volatility modules.
  
Build AI portfolio with Amphastar Stock
Check out the analysis of Amphastar Correlation against competitors.

Latest Amphastar's Ebitda Growth Pattern

Below is the plot of the Ebitda of Amphastar P over the last few years. It is Amphastar's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amphastar's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Amphastar Ebitda Regression Statistics

Arithmetic Mean72,419,225
Coefficient Of Variation144.95
Mean Deviation83,245,059
Median30,256,000
Standard Deviation104,968,135
Sample Variance11018.3T
Range311.3M
R-Value0.82
Mean Square Error3787.1T
R-Squared0.68
Significance0.000086
Slope18,170,350
Total Sum of Squares165274.6T

Amphastar Ebitda History

2025291.2 M
2024277.3 M
2023240.3 M
2022107.5 M
2021111.8 M
202030.2 M
201921.1 M

About Amphastar Financial Statements

Investors use fundamental indicators, such as Amphastar's Ebitda, to determine how well the company is positioned to perform in the future. Although Amphastar's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
EBITDA277.3 M291.2 M

Currently Active Assets on Macroaxis

When determining whether Amphastar P offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amphastar's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amphastar P Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amphastar P Stock:
Check out the analysis of Amphastar Correlation against competitors.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.37)
Earnings Share
2.76
Revenue Per Share
15.132
Quarterly Revenue Growth
(0.01)
Return On Assets
0.076
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amphastar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amphastar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amphastar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.